Features
- Rapid onset of action
- Short duration of effect due to rapid metabolism and elimination
Fresofol MCT/LCT (Propofol) Emulsion For Injection or Infusion 2%
Therapeutic Indications
Fresofol 2% is indicated for:
- maintenance of general anaesthesia in adults and children > 3 years of age
- induction and maintenance of general anaesthesia in adults and children > 3 years of age
- sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 16 years of age
- sedation of ventilated patients >16 years of age in the intensive care unit
Presentation
| Strengths | Packaging | Pack size* |
|---|---|---|
| 200 mg/20 ml | 200 ml glass ampoule | 5 |
| 200 mg/20 ml | 200 ml glass vials | 1, 5 or 10 |
| 500 mg/50 ml | 50 ml glass vials | 1, 10 or 15 |
| 1000 mg/100 ml | 100 ml glass vials | 1, 10 or 15 |
| 1000 mg/50 ml | 50 ml glass vials | 1, 10 or 15 |
* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only.
Product Information
Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.
If you require any information, please contact your local organization.
